Company intelligence / Profile preview

XII Medical

Union City, California, United Statesxiimedical.com ↗

Ownership: Private
Development stage: Preclinical

Overview

XII Medical is developing a minimally invasive, patient-centric neuromodulation device to treat moderate to severe obstructive sleep apnea. The company has raised significant venture funding and is advancing through clinical development. The technology aims to offer a less burdensome alternative to CPAP and other current therapies by providing a streamlined surgical approach with easier-to-use implantable devices. As of August 2024, the product remains investigational and not yet commercially available.

Therapeutic areas: Pulmonology
Modalities: DeviceNeuromodulation therapy system (medical device)
Industry: Implantable Medical Devices

Partnerships

Cleveland Clinic InnovationsAjax HealthIntuitive VenturesOmega FundsLongview Ventures/Broadview VenturesJobsOhio Growth Capital Fund

Beyond the preview

Go deeper on XII Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on XII Medical.

Explore the full profile